Literature DB >> 8272870

Location of cAMP-dependent protein kinase type I with the TCR-CD3 complex.

B S Skålhegg1, K Taskén, V Hansson, H S Huitfeldt, T Jahnsen, T Lea.   

Abstract

Selective activation of cyclic adenosine 3',5'-monophosphate (cAMP)-dependent protein kinase type I (cAKI), but not type II, is sufficient to mediate inhibition of T cell replication induced through the antigen-specific T cell receptor-CD3 (TCR-CD3) complex. Immunocytochemistry and immunoprecipitation studies of the molecular mechanism by which cAKI inhibits TCR-CD3-dependent T cell replication demonstrated that regulatory subunit I alpha, along with its associated kinase activity, translocated to and interacted with the TCR-CD3 complex during T cell activation and capping. Regulatory subunit II alpha did not. When stimulated by cAMP, the cAKI localized to the TCR-CD3 complex may release kinase activity that, through phosphorylation, might uncouple the TCR-CD3 complex from intracellular signaling systems.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8272870     DOI: 10.1126/science.8272870

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  40 in total

1.  Muscle-regulated expression and determinants for neuromuscular junctional localization of the mouse RIalpha regulatory subunit of cAMP-dependent protein kinase.

Authors:  S Barradeau; T Imaizumi-Scherrer; M C Weiss; D M Faust
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

Review 2.  Positive and negative regulation of T-cell activation through kinases and phosphatases.

Authors:  Tomas Mustelin; Kjetil Taskén
Journal:  Biochem J       Date:  2003-04-01       Impact factor: 3.857

Review 3.  Modulation of T cell immune functions by the prostaglandin E(2) - cAMP pathway in chronic inflammatory states.

Authors:  Kristoffer Watten Brudvik; Kjetil Taskén
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

4.  Designing isoform-specific peptide disruptors of protein kinase A localization.

Authors:  Lora L Burns-Hamuro; Yuliang Ma; Stefan Kammerer; Ulrich Reineke; Chris Self; Charles Cook; Gary L Olson; Charles R Cantor; Andreas Braun; Susan S Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-19       Impact factor: 11.205

Review 5.  A-kinase anchoring proteins as potential drug targets.

Authors:  Jessica Tröger; Marie C Moutty; Philipp Skroblin; Enno Klussmann
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

6.  D-AKAP2, a novel protein kinase A anchoring protein with a putative RGS domain.

Authors:  L J Huang; K Durick; J A Weiner; J Chun; S S Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

7.  The Ca(2+)-activated K(+) channel KCa3.1 compartmentalizes in the immunological synapse of human T lymphocytes.

Authors:  Stella A Nicolaou; Lisa Neumeier; Youqing Peng; Daniel C Devor; Laura Conforti
Journal:  Am J Physiol Cell Physiol       Date:  2006-12-06       Impact factor: 4.249

8.  Mutations and polymorphisms in the gene encoding regulatory subunit type 1-alpha of protein kinase A (PRKAR1A): an update.

Authors:  Anélia Horvath; Jérôme Bertherat; Lionel Groussin; Marine Guillaud-Bataille; Kitman Tsang; Laure Cazabat; Rosella Libé; Elaine Remmers; Fernande René-Corail; Fabio Rueda Faucz; Eric Clauser; Alain Calender; Xavier Bertagna; J Aidan Carney; Constantine A Stratakis
Journal:  Hum Mutat       Date:  2010-04       Impact factor: 4.878

9.  Protein kinase A-dependent and -independent signaling pathways contribute to cyclic AMP-stimulated proliferation.

Authors:  L A Cass; S A Summers; G V Prendergast; J M Backer; M J Birnbaum; J L Meinkoth
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

10.  Dual specificity A-kinase anchoring proteins (AKAPs) contain an additional binding region that enhances targeting of protein kinase A type I.

Authors:  Elisabeth Jarnaess; Anja Ruppelt; Anne Jorunn Stokka; Birgitte Lygren; John D Scott; Kjetil Taskén
Journal:  J Biol Chem       Date:  2008-09-29       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.